本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ocular Therapeutix

8.84
+0.21002.43%
成交量:81.83万
成交额:718.60万
市值:19.24亿
市盈率:-6.22
高:8.89
开:8.61
低:8.61
收:8.63
52周最高:16.44
52周最低:5.80
股本:2.18亿
流通股本:1.91亿
量比:0.47
换手率:0.43%
股息:- -
股息率:- -
每股收益(TTM):-1.4203
每股收益(LYR):-1.4203
净资产收益率:-54.85%
总资产收益率:-26.66%
市净率:2.94
市盈率(LYR):-6.22

数据加载中...

2026/02/27

重要事件披露

Form 8-K - Current report
2026/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/05

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/05

重要事件披露

Form 8-K - Current report
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

重要事件披露

Form 8-K - Current report
2025/12/18

重要事件披露

Form 8-K - Current report